149 related articles for article (PubMed ID: 31057396)
1. Focused Ultrasound Improves NK-92MI Cells Infiltration Into Tumors.
Yang C; Du M; Yan F; Chen Z
Front Pharmacol; 2019; 10():326. PubMed ID: 31057396
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule inhibitor HI-TOPK-032 improves NK-92MI cell infiltration into ovarian tumours.
Deng M; Yang R; Sun Q; Zhang J; Miao J
Basic Clin Pharmacol Toxicol; 2024 May; 134(5):629-642. PubMed ID: 38501576
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum: Focused Ultrasound Improves NK-92MI Cells Infiltration Into Tumors.
Yang C; Du M; Yan F; Chen Z
Front Pharmacol; 2019; 10():875. PubMed ID: 31413707
[TBL] [Abstract][Full Text] [Related]
4. [Killing Effect of A CD7 Chimeric Antigen Receptor-Modified NK-92MI Cell Line on CD7-Positive Hematological Malignant Cells].
Zhu XY; Liu X; Wang XB; Wang AY; Wang M; Liu NN; You FT; Pan GF; Yang L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1367-1375. PubMed ID: 32798428
[TBL] [Abstract][Full Text] [Related]
5. [Effect of demethylating treatment on cytotoxicity of NK-92MI cells].
Gao XN; Wang LL; Lin J; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):924-8. PubMed ID: 19698230
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cells activity against multiple myeloma cells is modulated by osteoblast-induced IL-6 and IL-10 production.
Uhl C; Nyirenda T; Siegel DS; Lee WY; Zilberberg J
Heliyon; 2022 Mar; 8(3):e09167. PubMed ID: 35846441
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells.
Shiozawa M; Chang CH; Huang YC; Chen YC; Chi MS; Hao HC; Chang YC; Takeda S; Chi KH; Wang YS
BMC Immunol; 2018 Aug; 19(1):27. PubMed ID: 30075754
[TBL] [Abstract][Full Text] [Related]
8. Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody.
Chen Y; You F; Jiang L; Li J; Zhu X; Bao Y; Sun X; Tang X; Meng H; An G; Zhang B; Yang L
Oncotarget; 2017 Jun; 8(23):37128-37139. PubMed ID: 28415754
[TBL] [Abstract][Full Text] [Related]
9. Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway.
Wang H; Yang J; Pan H; Tai MC; Maher MH; Jia R; Ge S; Lu L
Onco Targets Ther; 2020; 13():3903-3920. PubMed ID: 32440155
[TBL] [Abstract][Full Text] [Related]
10. Natural Killer Cell (NK-92MI)-Based Therapy for Pulmonary Metastasis of Anaplastic Thyroid Cancer in a Nude Mouse Model.
Zhu L; Li XJ; Kalimuthu S; Gangadaran P; Lee HW; Oh JM; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
Front Immunol; 2017; 8():816. PubMed ID: 28785259
[TBL] [Abstract][Full Text] [Related]
11. A Developed NK-92MI Cell Line with Siglec-7
Huang CH; Liao YJ; Fan TH; Chiou TJ; Lin YH; Twu YC
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29617289
[TBL] [Abstract][Full Text] [Related]
12. Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy.
Tam YK; Maki G; Miyagawa B; Hennemann B; Tonn T; Klingemann HG
Hum Gene Ther; 1999 May; 10(8):1359-73. PubMed ID: 10365666
[TBL] [Abstract][Full Text] [Related]
13. Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma.
Zhu L; Kalimuthu S; Gangadaran P; Oh JM; Lee HW; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
Theranostics; 2017; 7(10):2732-2745. PubMed ID: 28819459
[No Abstract] [Full Text] [Related]
14. Vanadium pentoxide prevents NK-92MI cell proliferation and IFNγ secretion through sustained JAK3 phosphorylation.
Gallardo-Vera F; Diaz D; Tapia-Rodriguez M; Fortoul van der Goes T; Masso F; Rendon-Huerta E; Montaño LF
J Immunotoxicol; 2016; 13(1):27-37. PubMed ID: 25565016
[TBL] [Abstract][Full Text] [Related]
15. Engraftment of mesothelin chimeric antigen receptor using a hybrid Sleeping Beauty/minicircle vector into NK-92MI cells for treatment of pancreatic cancer.
Batchu RB; Gruzdyn OV; Tavva PS; Kolli BK; Dachepalli R; Weaver DW; Gruber SA
Surgery; 2019 Oct; 166(4):503-508. PubMed ID: 31416604
[TBL] [Abstract][Full Text] [Related]
16. Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer.
Yang S; Cao B; Zhou G; Zhu L; Wang L; Zhang L; Kwok HF; Zhang Z; Zhao Q
Front Pharmacol; 2020; 11():1089. PubMed ID: 32848731
[TBL] [Abstract][Full Text] [Related]
17. Co-culture with NK-92MI cells enhanced the anti-cancer effect of bee venom on NSCLC cells by inactivation of NF-κB.
Kollipara PS; Kim JH; Won D; Lee SM; Sung HC; Chang HS; Lee KT; Lee KS; Park MH; Song MJ; Song HS; Hong JT
Arch Pharm Res; 2014 Mar; 37(3):379-89. PubMed ID: 24379113
[TBL] [Abstract][Full Text] [Related]
18. [Killer immunoglobulin-like receptor gene genotype and expression pattern in NK-92MI and K562 cells].
Dou LP; DA WM; Liu JH; Sun JF; Zhao Y; Wang QS; Gao CJ; Yu L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Sep; 25(9):767-9. PubMed ID: 19737456
[TBL] [Abstract][Full Text] [Related]
19. A novel CD7 chimeric antigen receptor-modified NK-92MI cell line targeting T-cell acute lymphoblastic leukemia.
You F; Wang Y; Jiang L; Zhu X; Chen D; Yuan L; An G; Meng H; Yang L
Am J Cancer Res; 2019; 9(1):64-78. PubMed ID: 30755812
[TBL] [Abstract][Full Text] [Related]
20. [Promoter methylation regulates KIR3DL1 gene expression in NK-92MI cell line].
Gao XN; Yu L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jul; 24(7):668-71. PubMed ID: 18616907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
